An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.
Clinical trial NCT04183634 · TERMINATED
Trial details
- NCT number
- NCT04183634
- Sponsor
- Sandoz
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-03
- Primary completion
- 2020-03-16
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.